0001396677-11-000035.txt : 20110927
0001396677-11-000035.hdr.sgml : 20110927
20110927180934
ACCESSION NUMBER: 0001396677-11-000035
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110927
FILED AS OF DATE: 20110927
DATE AS OF CHANGE: 20110927
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GAY FRANK W II
CENTRAL INDEX KEY: 0001079725
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23731
FILM NUMBER: 111110479
MAIL ADDRESS:
STREET 1: NUTRACETICAL INTERNATIONAL CORP
STREET 2: 1400 KEARNS BLVD 2ND FL.
CITY: PARK CITY
STATE: UT
ZIP: 84060
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NUTRACEUTICAL INTERNATIONAL CORP
CENTRAL INDEX KEY: 0001050007
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 870515089
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 1400 KEARNS BOULEVARD
STREET 2: 2ND FLOOR
CITY: PARK CITY
STATE: UT
ZIP: 84060
BUSINESS PHONE: 4356556000
MAIL ADDRESS:
STREET 1: 1400 KEARNS BOULEVARD
STREET 2: 2ND FLOOR
CITY: PARK CITY
STATE: UT
ZIP: 84060
4/A
1
primary_doc.xml
PRIMARY DOCUMENT
X0304
4/A
2011-09-27
2011-09-27
0
0001050007
NUTRACEUTICAL INTERNATIONAL CORP
NUTR
0001079725
GAY FRANK W II
NUTRACETICAL INTERNATIONAL CORP
1400 KEARNS BLVD 2ND FL.
PARK CITY
UT
84060
1
1
0
0
Chairman & CEO
Common Stock
2010-12-14
5
G
0
E
13000
0
D
727899
D
Common Stock
2011-09-23
4
M
0
5000
3.5
A
732899
D
Common Stock
2011-09-23
4
S
0
5000
13.2388
D
727899
D
Common Stock
2011-09-26
4
M
0
7000
3.5
A
734899
D
Common Stock
2011-09-26
4
S
0
7000
13.24
D
727899
D
Common Stock
2011-09-27
4
M
0
5900
3.5
A
733799
D
Common Stock
2011-09-27
4
S
0
5900
13.468
D
727899
D
Employee Stock Option (right to buy)
3.5
2011-09-23
4
M
0
5000
0
D
2011-12-13
Common Stock
5000
70000
D
Employee Stock Option (right to buy)
3.5
2011-09-26
4
M
0
7000
0
D
2011-12-13
Common Stock
7000
63000
D
Employee Stock Option (right to buy)
3.5
2011-09-27
4
M
0
5900
0
D
2011-12-13
Common Stock
5900
57100
D
Exercise of options expiring on December 13, 2011.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2011.
The price shown in Column 4 is a weighted average sale price. The price range for the sales is $13.12 to $13.31. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The price shown in this Column 4 is a weighted average sale price. The price range for the sales is $13.15 to $13.30. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The price shown in Column 4 is a weighted average sale price. The price range for the sales is $13.31 to $13.60. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The option vested in six equal installments beginning on June 13, 2002.
/s/ Alison Pitt, attorney in fact
2011-09-27